scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028362175 |
P356 | DOI | 10.1007/S10555-012-9384-6 |
P8608 | Fatcat ID | release_gdljqtok55gupj22kthy2mp5ii |
P698 | PubMed publication ID | 22706846 |
P2093 | author name string | Swethajit Biswas | |
John Lunec | |||
Kim Bartlett | |||
P2860 | cites work | Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK | Q21142775 |
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines | Q24314970 | ||
Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome | Q24338784 | ||
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells | Q24561962 | ||
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study | Q27851561 | ||
TOR signaling in growth and metabolism | Q27860757 | ||
On the Origin of Cancer Cells | Q27861025 | ||
Superoxide activates mitochondrial uncoupling proteins | Q28214829 | ||
Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets | Q28244291 | ||
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer | Q28253300 | ||
Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma | Q28281551 | ||
Mitochondrial tumour suppressors: a genetic and biochemical update | Q28285094 | ||
Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis | Q28472927 | ||
Genomic and mutational analysis of the mitochondrial trifunctional protein beta-subunit (HADHB) gene in patients with trifunctional protein deficiency | Q28645929 | ||
Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues | Q28646513 | ||
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer | Q30430510 | ||
Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family | Q31113056 | ||
Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence | Q33283342 | ||
mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. | Q33734395 | ||
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis | Q33914549 | ||
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism | Q33965102 | ||
Fatty acid oxidation disorders | Q34112648 | ||
Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system | Q34262892 | ||
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy | Q34296575 | ||
ATP citrate lyase inhibition can suppress tumor cell growth | Q34651116 | ||
Biochemical and physiological function of stearoyl-CoA desaturase | Q34898764 | ||
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis | Q35207795 | ||
Mitochondrial beta-oxidation | Q35631612 | ||
Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle | Q36274041 | ||
The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells | Q36661071 | ||
The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation | Q36925362 | ||
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism | Q37293677 | ||
Hypoxia-inducible factor 2 regulates hepatic lipid metabolism | Q37302297 | ||
The Randle cycle revisited: a new head for an old hat. | Q37337283 | ||
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy | Q37437194 | ||
Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity | Q37480801 | ||
The Akt-SREBP nexus: cell signaling meets lipid metabolism. | Q37684518 | ||
IDH mutations in glioma and acute myeloid leukemia | Q37778541 | ||
Cancer-associated IDH mutations: biomarker and therapeutic opportunities | Q37802750 | ||
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors | Q39878963 | ||
Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes | Q39906678 | ||
Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity | Q39918802 | ||
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction | Q40012089 | ||
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. | Q40012178 | ||
Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth | Q40222158 | ||
Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells | Q40430794 | ||
In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells | Q40496369 | ||
Genes for the human mitochondrial trifunctional protein alpha- and beta-subunits are divergently transcribed from a common promoter region | Q40967453 | ||
Mammalian mitochondrial beta-oxidation | Q41280085 | ||
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. | Q43081541 | ||
Molecular evolution of the metazoan PHD-HIF oxygen-sensing system | Q44193945 | ||
CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability | Q45152482 | ||
tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. | Q46450562 | ||
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma | Q46902015 | ||
The fatty acid synthase gene is a conserved p53 family target from worm to human. | Q47069045 | ||
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells | Q49145391 | ||
UCP3 protein regulation in human skeletal muscle fibre types I, IIa and IIx is dependent on exercise intensity. | Q54768942 | ||
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma☆ | Q58426214 | ||
P433 | issue | 3-4 | |
P921 | main subject | glycobiology | Q899224 |
P304 | page(s) | 689-698 | |
P577 | publication date | 2012-12-01 | |
P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
P1476 | title | Non-glucose metabolism in cancer cells--is it all in the fat? | |
P478 | volume | 31 |